1. How Should the FDA Review Diagnostic Radiopharmaceuticals?
2. Radioactive drugs, including biological products;Fed Regist.,1975
3. Title 21: food and drugs—chapter I: Food and Drug Administration Department of Health and Human Services—subchapter D: drugs for human use—part 312: investigational new drug application. U.S. Food and Drug Administration website. https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/cfrsearch.cfm?cfrpart=312. Updated August 14, 2017. Accessed March 27, 2018.
4. Committee for Proprietary Medicinal Products. Position paper on non-clinical safety studies to support clinical trials with a single microdose. Institute of Accelerator Analysis Ltd. website. http://www.iaa-ams.co.jp/img_bsnss/MD1.pdf. Published January 23, 2003. Accessed March 27, 2018.
5. Center for Drug Evaluation and Research. Guidance for industry, investigators, and reviewers: exploratory IND studies. Food and Drug Administration website. http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm078933.pdf. Published January 2006. Accessed March 27, 2018.